Stock analysts issued reports this on such companies as Apple (AAPL) - Get Apple Inc. (AAPL) Report, Intel (INTC) - Get Intel Corporation (INTC) Report and Amazon (AMZN) - Get Amazon.com, Inc. Report.
Regeneron Pharmaceuticals (REGN) - Get Regeneron Pharmaceuticals, Inc. Report was upgraded to buy from hold by SunTrust analyst Robyn Karnauskas, who also lifted her share-price target to $750 from $400.
JPMorgan Chase (JPM) - Get JPMorgan Chase & Co. (JPM) Report was upgraded to outperform by Wolfe analyst Steven Chubak, who also raised his rating on Wells Fargo (WFC) - Get Wells Fargo & Company Report to peer perform.
Intel was downgraded by Goldman Sachs analyst Toshiya Hari to sell from neutral with a price target of $54, down from $65.
Evolus (EOLS) - Get Evolus, Inc. Report was downgraded to neutral from buy by Mizuho analyst Vamil Divan, who slashed his share-price target to $3 from $8. SunTrust Robinson Humphrey also DocuSignhalved its share-price target for Evolus to $6
Price Target Changes
Amazon.com's price target was raised by Citi analyst Jason Bazinet to a Wall Street high of $3,550 to $2,700.
DocuSign (DOCU) - Get DocuSign, Inc. Report had its share price target raised by two firms. Wedbush, analyst Daniel Ives increased his share-price target to $240 from $165 and affirmed his outperform rating. J.P. Morgan analyst Patrick Walravens lifted his share-price target to $233 from $150, affirming his outperform rating.
Apple had its share price target raised to $400 from $380 by Deutsche Bank analyst Jeriel Ong, affirmed his buy rating.
Initiation of Coverage
Alibaba Group (BABA) - Get Alibaba Group Holding Ltd. Sponsored ADR Report was initiated with a buy rating Needham analyst Vincent Yu with a $275 share price target.